These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12147300)

  • 41. Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine.
    Saiko P; Steinmann MT; Schuster H; Graser G; Bressler S; Giessrigl B; Lackner A; Grusch M; Krupitza G; Bago-Horvath Z; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Phytomedicine; 2015 Jan; 22(1):213-22. PubMed ID: 25636891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Augmentation of 1-beta-D-arabinofuranosylcytosine (Ara-C) cytotoxicity in leukaemia cells by co-administration with antisignalling drugs.
    Freund A; Boos J; Harkin S; Schultze-Mosgau M; Veerman G; Peters GJ; Gescher A
    Eur J Cancer; 1998 May; 34(6):895-901. PubMed ID: 9797704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thiosemicarbazone derivatives, thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with arabinofuranosylcytosine.
    Graser-Loescher G; Schoenhuber A; Ciglenec C; Eberl S; Krupitza G; Mader RM; Jadav SS; Jayaprakash V; Fritzer-Szekeres M; Szekeres T; Saiko P
    Food Chem Toxicol; 2017 Oct; 108(Pt A):53-62. PubMed ID: 28716444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
    Ross DD; Akman SA; Joneckis CC; Yang E; Bachur NR
    Cancer Res; 1984 Apr; 44(4):1530-5. PubMed ID: 6584206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
    Leyden D; Ahmed N; Hassan HT
    Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic inhibition of human leukemia cell growth by deoxyguanosine and 1-beta-D-arabinofuranosylcytosine.
    Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR
    Biochem Pharmacol; 1984 Apr; 33(7):1059-63. PubMed ID: 6712715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells.
    Yamamoto S; Yamauchi T; Kawai Y; Takemura H; Kishi S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Int J Hematol; 2007 Feb; 85(2):108-15. PubMed ID: 17321987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S; Bhalla K; Rauscher F; Cadman E
    Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.
    Wang LM; White JC; Capizzi RL
    Cancer Chemother Pharmacol; 1990; 25(6):418-24. PubMed ID: 2311169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.
    Rudd SG; Tsesmetzis N; Sanjiv K; Paulin CB; Sandhow L; Kutzner J; Hed Myrberg I; Bunten SS; Axelsson H; Zhang SM; Rasti A; Mäkelä P; Coggins SA; Tao S; Suman S; Branca RM; Mermelekas G; Wiita E; Lee S; Walfridsson J; Schinazi RF; Kim B; Lehtiö J; Rassidakis GZ; Pokrovskaja Tamm K; Warpman-Berglund U; Heyman M; Grandér D; Lehmann S; Lundbäck T; Qian H; Henter JI; Schaller T; Helleday T; Herold N
    EMBO Mol Med; 2020 Mar; 12(3):e10419. PubMed ID: 31950591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
    Jarvis WD; Povirk LF; Turner AJ; Traylor RS; Gewirtz DA; Pettit GR; Grant S
    Biochem Pharmacol; 1994 Mar; 47(5):839-52. PubMed ID: 8135859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trimidox-mediated morphological changes during erythroid differentiation is associated with the stimulation of hemoglobin and F-cell production in human K562 cells.
    Iyamu EW; Adunyah SE; Elford HL; Fasold H; Turner EA
    Biochem Biophys Res Commun; 1998 Jun; 247(3):759-64. PubMed ID: 9647767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling.
    Jarvis WD; Fornari FA; Tombes RM; Erukulla RK; Bittman R; Schwartz GK; Dent P; Grant S
    Mol Pharmacol; 1998 Nov; 54(5):844-56. PubMed ID: 9804619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells.
    Chen P; Aimiuwu J; Xie Z; Wei X; Liu S; Klisovic R; Marcucci G; Chan KK
    AAPS J; 2011 Mar; 13(1):131-40. PubMed ID: 21191677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GM-CSF and asparaginase potentiate ara-C cytotoxicity in HL-60 cells.
    Powell BL; Wang LM; Gregory BW; Case LD; Kucera GL
    Leukemia; 1995 Mar; 9(3):405-9. PubMed ID: 7885038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
    Vilpo JA; Vilpo LM
    Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
    Roberts D; Peck C
    Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.
    Kubota M; Takimoto T; Tanizawa A; Akiyama Y; Mikawa H
    Biochem Pharmacol; 1988 May; 37(9):1745-9. PubMed ID: 2454114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.